| [1] |
LI Shunan, ZHANG Shiyan, DENG Yanan, HU Danqing, ZHENG Yuxin, LI Danyang, LI Candong.
An Analysis of Trends and Prediction of Disease Burden for Type 2 Diabetic Nephropathy from 1990 to 2021 in China
[J]. Chinese General Practice, 2025, 28(33): 4214-4226.
|
| [2] |
ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei.
Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy
[J]. Chinese General Practice, 2025, 28(26): 3307-3313.
|
| [3] |
ADILI Tuersun, CHENG Gang.
Meta-analysis of the Efficacy and Safety of Finerenone in the Treatment of Type 2 Diabetic Nephropathy
[J]. Chinese General Practice, 2025, 28(21): 2686-2691.
|
| [4] |
WANG Linna, ZHANG Jinghui.
Expression and Prognostic Value of Serum SAA, IL-6, TNF-α and microRNAs in Children with Sepsis Complicated with Acute Kidney Injury
[J]. Chinese General Practice, 2025, 28(03): 293-298.
|
| [5] |
HAN Junjie, WU Di, CHEN Zhisheng, XIAO Yang, SEN Gan.
A Nomogram Prediction Model and Validation Study on the Risk of Complicated Diabetic Nephropathy in Type 2 Diabetes Patients
[J]. Chinese General Practice, 2024, 27(09): 1054-1061.
|
| [6] |
ZOU Qiong, WU Xi, ZHANG Yang, WAN Yi, CHEN Changsheng.
Prediction of Type 2 Diabetic Nephropathy Based on BP Neural Network Optimized by Sparrow Search Algorithm
[J]. Chinese General Practice, 2024, 27(08): 961-970.
|
| [7] |
LIN Xiaomei, ZUMURETI Abudukiyimu, MA Chunhui, XU Mengge, MA Juxing, LI Xia.
Study on the Correlation of Serum Interleukin-6 and Fasting Blood Glucose with Coronary Heart Disease and Adverse Cardiovascular Events
[J]. Chinese General Practice, 2024, 27(03): 286-292.
|
| [8] |
WU Zixing, HU Xin, TAO Shimeng, HE Youjun, CAI Chuanyun, JIANG Wei.
Correlations of Cognitive Function with Insomnia Severity, Serum Levels of 25-hydroxy Vitamin D3 and Tumor Necrosis Factor-α in Elderly Patients with Chronic Insomnia
[J]. Chinese General Practice, 2024, 27(03): 328-334.
|
| [9] |
DENG Yuxuan, HUANG Xuejun, JIANG Yanxia.
Recent Advances of Metformin in Treatment of Diabetic Nephropathy
[J]. Chinese General Practice, 2024, 27(03): 262-267.
|
| [10] |
ZUMURETI ·Abudukeyimu, MA Yanlin, ZHU Kairui, LIU Fang, LI Xia.
Correlation of Early Growth Response 3 and Interleukin 6 Expression Levels with Coronary Heart Disease
[J]. Chinese General Practice, 2023, 26(24): 3016-3021.
|
| [11] |
ZHAO Lizhen, LI Weimin, JIANG Ruixia.
Clinical Value of Systemic Immune-inflammation Index in the Diagnosis of Diabetic Kidney Disease in Community-dwelling Elderly Patients with Type 2 Diabetes
[J]. Chinese General Practice, 2023, 26(18): 2227-2231.
|
| [12] |
SHU Tao, GUO Zheng, WANG Fei, CHEN Shuyan.
Analysis of the Correlation between Time in Range and Diabetic Kidney Disease
[J]. Chinese General Practice, 2023, 26(15): 1873-1879.
|
| [13] |
YAN Peng, SONG Jianling, FANG Xiangdong.
Recent Developments in Parathyroid Hormone Type 1 Receptor and Kidney Disease
[J]. Chinese General Practice, 2023, 26(11): 1398-1403.
|
| [14] |
SHEN Fei, JIANG Weiping, MEI Xiaobin, HAN Yiping, ZHAO Jiayi, FAN Jian, GU Juan, SHEN Yanhong, XU Hongmei, ZHANG Dan, MEN Ying, DING Haiguang, CHEN Caiping, HAN Junhua.
Influence of Microbiota-modulating Agents on Gut Flora in Community Patients with Diabetic Nephropathy
[J]. Chinese General Practice, 2023, 26(09): 1112-1117.
|
| [15] |
Yujie WANG, Jian WANG, Jingwei ZHOU.
Effect of Qingre Xiaozheng Formula on Improving Renal Injury in a Rat Model of Diabetic Kidney Disease
[J]. Chinese General Practice, 2022, 25(29): 3678-3685.
|